Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

REACH

This article was originally published in The Rose Sheet

Executive Summary

The European Parliament's Committee on the Environment, Public Health and Food Safety has voted to strengthen the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) legislation during a meeting Oct. 10. The vote passed with 42 members in favor, 12 opposed and six abstentions. Amendments to the legislation include establishing a quality mark for REACH-compliant products, increased focus on alternatives to animal testing and a requirement for substituting compounds deemed "the most hazardous substances" with less toxic ingredients. REACH will undergo a deliberation in the near term before the entire Parliament before it is reviewed by the EU Council of Ministers. Slated to go into effect in the first quarter of next year, REACH requires importers and manufacturers of more than one ton of chemical per year to register with a European chemicals agency. A proposal for the legislation was overhauled in 2003 to reduce burdens on downstream users (1"The Rose Sheet" Nov. 3, 2003, p. 11)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel